申请人:Rhone-Poulenc Rorer S.A.
公开号:US05382590A1
公开(公告)日:1995-01-17
Compounds of formula: ##STR1## in which R.sub.1 represents a hydrogen atom or an alkyl, alkoxycarbonyl or an unsubstituted or substituted phenyl radical, R.sub.2 represents a hydrogen atom or an unsubstituted or substituted alkyl radical, R.sub.3 represents an alkyl, phenylalkyl, indanyl, cycloalkylalkyl or an unsubstituted or substituted phenyl radical, or R.sub.2 and R.sub.3 form a heterocycle together with the nitrogen atom to which they are attached, and R.sub.4 represents an unsubstituted or substituted phenyl radical, a naphthyl, indolyl or quinolyl radical or a phenylamino radical in which the phenyl ring is unsubstituted or substituted, their preparation and medicaments containing them.
公式为:##STR1##,其中R.sub.1代表氢原子或烷基、烷氧羰基或未取代或取代的苯基基团,R.sub.2代表氢原子或未取代或取代的烷基基团,R.sub.3代表烷基、苯基烷基、茚基、环烷基烷基或未取代或取代的苯基基团,或R.sub.2和R.sub.3与它们连接的氮原子一起形成一个杂环,R.sub.4代表未取代或取代的苯基基团、萘基、吲哚基或喹啉基团或苯胺基团,其中苯环未取代或取代,它们的制备以及含有它们的药物。